MedPath

The IDEAL Study: a clinical trial of the timing of kidney dialysis initiation on survival in subjects with chronic kidney disease.

Not Applicable
Completed
Conditions
Chronic Kidney disease
Cardiac disease
Nutrition
Renal and Urogenital - Kidney disease
Registration Number
ACTRN12609000266268
Lead Sponsor
Steering Committee of the IDEAL Study
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
800
Inclusion Criteria

Age greater than 18 years. Progressive chronic kidney disease. GFR between 10-20ml/min/1.73m^2.

Exclusion Criteria

Significant cancer. Planned live renal transplant in the next 12 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All cause mortality[At the end of the trial. 800 patients will be followed every 3 months for a minimum of 3 years post randomization.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath